Cardiovascular Diabetology

Table 5 The effect of 1 standard deviation increase in risk scores or clinical biomarkers on echocardiographic parameters

From: Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

Variable	Standardized β, p-value				R²
Variable	ARIC-HF^	WATCH-DM^	NTpBNP*	hs-TnT*	ARIC-HF^	WATCH-DM^	NTpBNP*	hs-TnT*
GLS	0.22, p < 0.001	0.22, p < 0.001	0.32, p < 0.001	0.26, p < 0.001	0.05	0.05	0.18	0.14
E/e’	0.09, p = 0.015	0.33, p < 0.001	0.32, p < 0.001	0.29, p < 0.001	0.01	0.11	0.17	0.16
e’	−0.07, p = 0.060	−0.27, p < 0.001	−0.12, p = 0.001	−0.15, p = 0.001	0.005	0.08	0.08	0.09
LAVi	0.01, p = 0.813	0.23, p < 0.001	0.22, p < 0.001	0.15, p = 0.001	0.0001	0.04	0.10	0.06
LVMi	0.09, p = 0.014	0.23, p < 0.001	0.15, p < 0.001	0.24, p < 0.001	0.008	0.05	0.07	0.09

^univariable linear regression analysis, *multivariable linear regression analysis adjusted for age, body mass index and renal function
95% CI = 95% confidence interval; GLS = global longitudinal strain; hs-TnT = high sensitivity troponin-T; LAVi = left atrial volume indexed to body surface area; LVMi = left ventricular mass indexed to body surface area

Back to article page

ISSN: 1475-2840

Contact us

Submission enquiries: journalsubmissions@springernature.com